Locoid C cream

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Chlorquinaldol; Hydrocortisone butyrate

Available from:

Astellas Pharma Ltd

ATC code:

D07BB04

INN (International Name):

Chlorquinaldol; Hydrocortisone butyrate

Dosage:

30mg/1gram ; 1mg/1gram

Pharmaceutical form:

Cutaneous cream

Administration route:

Cutaneous

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 13040000

Patient Information leaflet

IAT001-00 (LFT293) Page 1+2, 145 x 270 mm
145 mm
270 mm
Insert
145 x 270 mm
IAT001-00
15/08/2016
JUG
100%
Used for:
Comments:
059659-XX
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor, pharmacist or
nurse.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their
signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side effects
not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What Locoid Cream is and what it is used for
2. What you need to know before you use Locoid Cream
3. How to use Locoid Cream
4. Possible side effects
5. How to store Locoid Cream
6. Contents of the pack and other information
1. WHAT LOCOID CREAM IS AND WHAT IT IS USED FOR
Locoid Cream contains the active substance hydrocortisone butyrate.
This is a corticosteroid which when
made up as a cream is for use on the skin. This is known as topical
application. Topical corticosteroids are
ranked as mildly potent, moderately potent, potent and very potent;
Locoid Cream is classed as potent.
Topical corticosteroids are able to reduce the inflammation caused by
a variety of skin conditions, and so
allow it to get better. They can also affect the cause of the
condition, which can lead to its healing.
Locoid Cream is indicated in adults, children and infants. It is used
to treat a variety of skin conditions that
respond to topical corticosteroids. Among these are eczema and
dermatitis (itching) of all types including
atopic (childhood) eczema, photodermatitis (itching caused by exposure
to light) and dermatitis caused by
skin irritants and allergies.
It can also be used in the treatment of psoriasis, a condition
resulting in thickening of areas of the skin. It is
important that you follow your doctor’s instru

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Locoid cream
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Locoid Cream contains 0.1% w/w hydrocortisone butyrate.
Excipient(s) with known effect:
Cetostearyl alcohol (7.2% w/w)
Butyl parahydroxybenzoate (0.05% w/w)
Propyl parahydroxybenzoate (0.1% w/w)
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Cream.
The product is a white to practically white cream.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Locoid Cream is indicated in adults, children and infants. The product
is
recommended for clinical use in the treatment of conditions responsive
to
topical corticosteroids e.g. eczema, dermatitis and psoriasis.
Topical corticosteroids are not generally indicated in psoriasis but
may be
acceptable in psoriasis excluding widespread plaque psoriasis provided
warnings are given, see section 4.4 Special warnings and precautions
for use.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults and older people _
The same dose is used for adults and older people, as clinical
evidence would
indicate that no special dosage regimen is necessary in older people.
_Paediatric population _
Long term treatment should be avoided where possible.
_Infants _
Therapy should be limited if possible to a maximum of seven days.
Method of administration
For cutaneous use.
Dosage: To be applied evenly and sparingly no more than twice daily.
Application may be made under occlusion in the more resistant lesions
such as
thickened psoriatic plaques on elbows and knees.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients
listed in
section 6.1.
This preparation is contraindicated in the presence of untreated viral
or fungal
infections, tubercular or syphilitic lesions, peri-oral dermatitis,
acne vulgaris
and rosacea and in bacterial infections unless used in connection with
appropriate chemotherapy.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Application under occlusion should be restricted to dermatoses
involving